The information on the use of biologic agents blocking B-cell activating factor and A proliferation inducing ligand for patients with lupus, rheumatoid arthritis, Sjögren’s syndrome and myositis has been updated. Therapeutic Advances in Musculoskeletal Disease, 07/17/2015. (Also see Biologic Agents)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.